Dexamethasone Regulates EphA5, a Potential Inhibitory Factor with Osteogenic Capability of Human Bone Marrow Stromal Cells
We previously demonstrated the importance of quality management procedures for the handling of human bone marrow stromal cells (hBMSCs) and provided evidence for the existence of osteogenic inhibitor molecules in BMSCs. One candidate inhibitor is the ephrin type-A receptor 5 (EphA5), which is expres...
Saved in:
| Main Authors: | Tsuyoshi Yamada, Toshitaka Yoshii, Hiroaki Yasuda, Atsushi Okawa, Shinichi Sotome |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2016/1301608 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EphA‐Mediated Regulation of Stomatin Expression in Prostate Cancer Cells
by: Masanari Nishida, et al.
Published: (2024-10-01) -
Increased Serum EphA2 is Associated with Disease Severity in Pediatric Patients with Asthma
by: Ma S, et al.
Published: (2025-04-01) -
Ephrin-A5 or EphA7 stimulation is anti-proliferative for human rhabdomyosarcoma in vitro
by: Alessandra Cecchini, et al.
Published: (2025-05-01) -
RETRACTED: The Expression of ephrinA1/ephA2 Receptor Increases in Chronic Rhinosinusitis and ephrinA1/ephA2 Signaling Affects Rhinovirus-Induced Innate Immunity in Human Sinonasal Epithelial Cells
by: Sang Hag Lee, et al.
Published: (2021-12-01) -
EphA5 Silencing Increases the Radiosensitivity of ESCC Cells Through ATM-Dependent Pathway [Retraction]
by: Zhang R, et al.
Published: (2025-07-01)